A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Summary

This study primary objective and endpoints are compare the efficacy of two products containing filgrastim, evaluating if the formulation produced by Eurofarma can be considered non-inferior to the reference product.

Timeline

Start

2011-03

Primary completion

2011-04

Completion

2012-10

Drugs

Indications